23943-98-8 Usage
Uses
Used in Pharmaceutical Synthesis:
[S,(-)]-2-Methoxypropionyl chloride is used as an intermediate in the synthesis of pharmaceuticals for its reactive nature, which allows for the creation of various drug compounds.
Used in Agrochemical Production:
[S,(-)]-2-Methoxypropionyl chloride is also utilized as an intermediate in the production of agrochemicals, contributing to the development of substances used in agriculture.
Used in Fragrance Industry:
[S,(-)]-2-Methoxypropionyl chloride is used as a building block in the fragrance industry, where its reactivity helps in creating a wide range of scents.
Used in Dye Manufacturing:
In the dye manufacturing industry, [S,(-)]-2-Methoxypropionyl chloride is used as an intermediate to produce various types of dyes due to its ability to form different chemical structures.
Used in Specialty Chemicals:
[S,(-)]-2-Methoxypropionyl chloride is also employed in the production of specialty chemicals, where its unique properties are harnessed for specific applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 23943-98-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,4 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 23943-98:
(7*2)+(6*3)+(5*9)+(4*4)+(3*3)+(2*9)+(1*8)=128
128 % 10 = 8
So 23943-98-8 is a valid CAS Registry Number.
23943-98-8Relevant academic research and scientific papers
SPIRO-CONDENSED 1, 3, 4-THIADIAZOLE DERIVATIVES FOR INHIBITING KSP KINESIN ACTIVITY
-
Page/Page column 377, (2009/05/28)
The present invention relates to compounds of Formula (I), below, (wherein X, R1, R2, R3, p, E, ring A, and ring B are as defined herein). The present invention also relates to compositions (including pharmaceutically acceptable compositions) comprising t
Substituted 3-amino-sydnonimines, their use and pharmaceutical products containing them
-
, (2008/06/13)
Optically active substituted 3-aminosydnonimines of the general formula I STR1 and their pharmacologically acceptable acid addition salts, wherein R1 denotes, for example, the radical R3 (R4)N-, R2 denotes the radical 1-methoxyethyl (--CH(CH3)OCH3), acetoxy-phenyl-methyl (--CH(C6 H5)O--COCH3), 1-(ethoxycarbonyl)-ethoxy (--O--CH3)CO2 C2 H5), R3 denotes alkyl(C1 -C4) and R4 denotes for example alkyl(C1 -C4), possess valuable pharmaceutical properties.
